# P&C PRODUCTS · 66-41 · ITALY — FDA import alert red lists: firms subject to detention without physical examination

For P&C PRODUCTS · 66-41 · ITALY, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is ITALY; product is Neoprosone-Gel Forte | Neoprosone-Gel Forte; product code is 64 L - - 67 Clobetasol Propionate (Glucocorticoid) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 10/01/2021; address is Largo Desio , Milan, Milan ITALY, verified against its source on 2026-09-16.

- **Firm:** P&C PRODUCTS _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** ITALY _(verified: appears in the quote below)_
- **Address:** Largo Desio , Milan, Milan ITALY _(verified: appears in the quote below)_
- **Date published:** 10/01/2021 _(verified: appears in the quote below)_
- **Product code:** 64 L - - 67 Clobetasol Propionate (Glucocorticoid) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. _(verified: each item appears in the quote below)_
- **Product:** Neoprosone-Gel Forte | Neoprosone-Gel Forte _(verified: each item appears in the quote below)_
- **FDA notes:** The product appears to be an unapproved new drug as the product’s informational insert includes claims such as (not an all-inclusive list): ‘is a pharmaceutical product effective against acute dermatitis: eczema, psoriasis, itchiness, local inflammations and allergic reactions…’. | The product appears to be an unapproved new drug as the product’s informational insert includes claims such as (not an all-inclusive list): ‘is a pharmaceutical product effective against acute dermatitis: eczema, psoriasis, itchiness, local inflammations and allergic reactions…’. _(verified: each item appears in the quote below)_

## What the source says

> P&C PRODUCTS Date Published : 10/01/2021 Largo Desio , Milan, Milan ITALY 64 L - - 67 Clobetasol Propionate (Glucocorticoid) Date Published: 10/01/2021 Desc: Neoprosone-Gel Forte Notes: The product appears to be an unapproved new drug as the product’s informational insert includes claims such as (not an all-inclusive list): ‘is a pharmaceutical product effective against acute dermatitis: eczema, psoriasis, itchiness, local inflammations and allergic reactions…’. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 10/01/2021 Desc: Neoprosone-Gel Forte Notes: The product appears to be an unapproved new drug as the product’s informational insert includes claims such as (not an all-inclusive list): ‘is a pharmaceutical product effective against acute dermatitis: eczema, psoriasis, itchiness, local inflammations and allergic reactions…’.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).